open access

Vol 91, No 3 (2020)
REVIEW PAPERS Obstetrics
Published online: 2020-03-31
Get Citation

Periodontitis and risk for preeclampsia — a systematic review

Tomasz Konopka, Aneta Zakrzewska
DOI: 10.5603/GP.2020.0024
·
Pubmed: 32266957
·
Ginekol Pol 2020;91(3):158-164.

open access

Vol 91, No 3 (2020)
REVIEW PAPERS Obstetrics
Published online: 2020-03-31

Abstract

Objectives: The aim of the study is to review systematic cohort and randomized trials on the relationship between periodontitis and preeclampsia. Periodontitis is an independent risk factor for preeclampsia (PE), and periodontal treatment could play a significant role in the prevention of this pregnancy complication. Material and methods: A total of 821 items (published until March 2019), thematically related to the relationship between periodontitis, its treatment and the incidence of preeclampsia, were collected from the databases of PubMed, Scopus, Google Scholar and the Polish Database of Medical Bibliography and analyzed. In the end, 6 cohort studies and 3 randomized controlled trials (from the years 2003–2016) were deemed eligible for the review. The main exclusion criteria were as follows: case-control and cross-sectional studies, medical and dental conditions. Results: A significant relationship between periodontitis and the risk for developing preeclampsia was demonstrated in 5 cohort trials, which was not confirmed by only 1 study. A total of 2724 pregnant women, including 195 (7.16%) with PE, were analyzed. In 3 randomized trials which assessed the impact of non-surgical treatment (scaling and root planing = SRP) on the occurrence of preeclampsia, the preventive effects of the implemented treatment was not confirmed. A total of 116 women from the group of 1825 pregnant subjects undergoing the non-surgical treatment (SRP) and 116 women from the control group of 1827 pregnant women were subsequently diagnosed with PE, which amounted to 6.30% and 6.35%, respectively. Conclusions: The cohort studies indicated that periodontitis may result in an increased risk for developing PE. A more detailed analysis regarding the impact of potential risk factors and modification of further studies (clarification of how periodontitis and preeclampsia should be defined in observations, consideration of disease severity, earlier at 12–16 weeks of gestation — implementation of the non-surgical treatment, modification and extension of the classical protocol of the non-surgical treatment of periodontal diseases, as well as conducting European studies), are necessary due to considerable discrepancies in the available literature sources (cohort and randomized observations).

Abstract

Objectives: The aim of the study is to review systematic cohort and randomized trials on the relationship between periodontitis and preeclampsia. Periodontitis is an independent risk factor for preeclampsia (PE), and periodontal treatment could play a significant role in the prevention of this pregnancy complication. Material and methods: A total of 821 items (published until March 2019), thematically related to the relationship between periodontitis, its treatment and the incidence of preeclampsia, were collected from the databases of PubMed, Scopus, Google Scholar and the Polish Database of Medical Bibliography and analyzed. In the end, 6 cohort studies and 3 randomized controlled trials (from the years 2003–2016) were deemed eligible for the review. The main exclusion criteria were as follows: case-control and cross-sectional studies, medical and dental conditions. Results: A significant relationship between periodontitis and the risk for developing preeclampsia was demonstrated in 5 cohort trials, which was not confirmed by only 1 study. A total of 2724 pregnant women, including 195 (7.16%) with PE, were analyzed. In 3 randomized trials which assessed the impact of non-surgical treatment (scaling and root planing = SRP) on the occurrence of preeclampsia, the preventive effects of the implemented treatment was not confirmed. A total of 116 women from the group of 1825 pregnant subjects undergoing the non-surgical treatment (SRP) and 116 women from the control group of 1827 pregnant women were subsequently diagnosed with PE, which amounted to 6.30% and 6.35%, respectively. Conclusions: The cohort studies indicated that periodontitis may result in an increased risk for developing PE. A more detailed analysis regarding the impact of potential risk factors and modification of further studies (clarification of how periodontitis and preeclampsia should be defined in observations, consideration of disease severity, earlier at 12–16 weeks of gestation — implementation of the non-surgical treatment, modification and extension of the classical protocol of the non-surgical treatment of periodontal diseases, as well as conducting European studies), are necessary due to considerable discrepancies in the available literature sources (cohort and randomized observations).

Get Citation

Keywords

periodontitis; periodontal therapy; adverse obstetric outcomes; preeclampsia; systematic review

About this article
Title

Periodontitis and risk for preeclampsia — a systematic review

Journal

Ginekologia Polska

Issue

Vol 91, No 3 (2020)

Pages

158-164

Published online

2020-03-31

DOI

10.5603/GP.2020.0024

Pubmed

32266957

Bibliographic record

Ginekol Pol 2020;91(3):158-164.

Keywords

periodontitis
periodontal therapy
adverse obstetric outcomes
preeclampsia
systematic review

Authors

Tomasz Konopka
Aneta Zakrzewska

References (36)
  1. Górska R, Dembowska E, Pietruska M, et al. Częstość występowania chorób przyzębia i chorób błony śluzowej jamy ustnej u osób w wieku 35-44 i 65-74 lata w wybranych miastach Polski. Streszczenia 12 Kongresu tologów Polskich. J Stoma. 2014; 67(Supl. 1): 57.
  2. AlJehani YA. Risk factors of periodontal disease: review of the literature. Int J Dent. 2014; 2014: 182513.
  3. Borakowska-Siennicka M. Stan przyzębia i higieny jamy ustnej u kobiet ciężarnych. Nowa Stomatol. 2002; 7(4): 199–203.
  4. Gaszyńska E, Klepacz-Szewczyk J, Trafalska E, et al. Dental awareness and oral health of pregnant women in Poland. Int J Occup Med Environ Health. 2015; 28(3): 603–611.
  5. Konopka T, Paradowska-Stolarz A. Periodontitis and risk of preterm birth and low birthweight--a meta-analysis. Ginekol Pol. 2012; 83(6): 446–453.
  6. Journal of Clinical Periodontology. 2013; 40(1).
  7. Steegers E, Dadelszen Pv, Duvekot J, et al. Pre-eclampsia. The Lancet. 2010; 376(9741): 631–644.
  8. Poon L, Shennan A, Hyett J, et al. The International Federation of Gynecology and Obstetrics ( FIGO ) initiative on pre‐eclampsia: A pragmatic guide for first‐trimester screening and prevention. International Journal of Gynecology & Obstetrics. 2019; 145(S1): 1–33.
  9. Poprawski G. Markery predykcji stanu przedrzucawkowego a przebieg ciąży powikłanej cukrzycą przedciążową. Praca doktorska (Doctoral thesis), UM w Poznaniu. ; 2014: 10–22.
  10. Bartsch E, Medcalf KE, Park AL, et al. High Risk of Pre-eclampsia Identification Group. Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies. BMJ. 2016; 353: i1753.
  11. Riché EL, Boggess KA, Lieff S, et al. Periodontal disease increases the risk of preterm delivery among preeclamptic women. Ann Periodontol. 2002; 7(1): 95–101.
  12. Moher D, Liberati A, Tetzlaff J, et al. PRISMA Group, PRISMA Group, PRISMA Group, PRISMA Group, PRISMA Group, PRISMA Group, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. Open Med. 2009; 3(3): e123–e130.
  13. Kumar A, Basra M, Begum N, et al. Association of maternal periodontal health with adverse pregnancy outcome. J Obstet Gynaecol Res. 2013; 39(1): 40–45.
  14. Horton AL, Boggess KA, Moss KL, et al. Periodontal disease, oxidative stress, and risk for preeclampsia. J Periodontol. 2010; 81(2): 199–204.
  15. Lee HJ, Ha JE, Bae KH. Synergistic effect of maternal obesity and periodontitis on preterm birth in women with pre-eclampsia: a prospective study. J Clin Periodontol. 2016; 43(8): 646–651.
  16. Herrera JA, Velez-Medina S, Molano R, et al. Periodontal intervention effects on pregnancy outcomes in women with preeclampsia. Colomb Med. 2009; 40(2): 177–184.
  17. Boggess KA, Berggren EK, Koskenoja V, et al. Severe preeclampsia and maternal self-report of oral health, hygiene, and dental care. J Periodontol. 2013; 84(2): 143–151.
  18. Boggess KA, Lieff S, Murtha AP, et al. Maternal periodontal disease is associated with an increased risk for preeclampsia. Obstet Gynecol. 2003; 101(2): 227–231.
  19. Srinivas SK, Sammel MD, Stamilio DM, et al. Periodontal disease and adverse pregnancy outcomes: is there an association? Am J Obstet Gynecol. 2009; 200(5): 497.e1–497.e8.
  20. Shetty M, Shetty PK, Ramesh A, et al. Periodontal disease in pregnancy is a risk factor for preeclampsia. Acta Obstet Gynecol Scand. 2010; 89(5): 718–721.
  21. Kumar A, Begum N, Prasad S, et al. Role of cytokines in development of pre-eclampsia associated with periodontal disease - Cohort Study. J Clin Periodontol. 2014; 41(4): 357–365.
  22. Ha JE, Jun JK, Ko HJ, et al. Association between periodontitis and preeclampsia in never-smokers: a prospective study. J Clin Periodontol. 2014; 41(9): 869–874.
  23. Soucy-Giguère L, Tétu A, Gauthier S, et al. Periodontal Disease and Adverse Pregnancy Outcomes: A Prospective Study in a Low-Risk Population. J Obstet Gynaecol Can. 2016; 38(4): 346–350.
  24. Michalowicz BS, Hodges JS, DiAngelis AJ, et al. OPT Study. Treatment of periodontal disease and the risk of preterm birth. N Engl J Med. 2006; 355(18): 1885–1894.
  25. Offenbacher S, Beck JD, Jared HL, et al. Maternal Oral Therapy to Reduce Obstetric Risk (MOTOR) Investigators. Effects of periodontal therapy on rate of preterm delivery: a randomized controlled trial. Obstet Gynecol. 2009; 114(3): 551–559.
  26. Newnham JP, Newnham IA, Ball CM, et al. Treatment of periodontal disease during pregnancy: a randomized controlled trial. Obstet Gynecol. 2009; 114(6): 1239–1248.
  27. Sgolastra F, Petrucci A, Severino M, et al. Relationship between periodontitis and pre-eclampsia: a meta-analysis. PLoS One. 2013; 8(8): e71387.
  28. Wei BJ, Chen YJ, Yu Li, et al. Periodontal disease and risk of preeclampsia: a meta-analysis of observational studies. PLoS One. 2013; 8(8): e70901.
  29. Huang Xi, Wang J, Liu J, et al. Maternal periodontal disease and risk of preeclampsia: a meta-analysis. J Huazhong Univ Sci Technolog Med Sci. 2014; 34(5): 729–735.
  30. Zi M, Longo P, Bueno-Silva B, et al. Mechanisms Involved in the Association between Periodontitis and Complications in Pregnancy. Frontiers in Public Health. 2015; 2.
  31. Shiadeh MN, Moghadam ZB, Adam I, et al. Human infectious diseases and risk of preeclampsia: an updated review of the literature. Infection. 2017; 45(5): 589–600.
  32. Kunnen A, van Doormaal JJ, Abbas F, et al. Periodontal disease and pre-eclampsia: a systematic review. J Clin Periodontol. 2010; 37(12): 1075–1087.
  33. Iheozor-Ejiofor Z, Middleton P, Esposito M, et al. Treating periodontal disease for preventing adverse birth outcomes in pregnant women. Cochrane Database Syst Rev. 2017; 6: CD005297.
  34. Novak MJ, Novak KF, Hodges JS, et al. Periodontal bacterial profiles in pregnant women: response to treatment and associations with birth outcomes in the obstetrics and periodontal therapy (OPT) study. J Periodontol. 2008; 79(10): 1870–1879.
  35. Pirie M, Linden G, Irwin C. Intrapregnancy non-surgical periodontal treatment and pregnancy outcome: a randomized controlled trial. J Periodontol. 2013; 84(10): 1391–1400.
  36. Penova-Veselinovic B, Keelan JA, Wang CA, et al. Changes in inflammatory mediators in gingival crevicular fluid following periodontal disease treatment in pregnancy: relationship to adverse pregnancy outcome. J Reprod Immunol. 2015; 112: 1–10.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl